Año: 2019
Journal Impact Factor (JIF): 20.860
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| CELL & TISSUE ENGINEERING | SCIE | 1/29 | Q1 | T1 | D1 |
| CELL BIOLOGY | SCIE | 6/195 | Q1 | T1 | D1 |
Año: 2019
Journal Citation Indicator (JCI): 4,430
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| CELL & TISSUE ENGINEERING | 1/31 | Q1 | T1 | D1 | 98,39 |
| CELL BIOLOGY | 7/200 | Q1 | T1 | D1 | 96,75 |
Año:
2019
CiteScore:
35,700
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Cell Biology | 4/274 | Q1 | T1 | D1 |
| Genetics | 3/324 | Q1 | T1 | D1 |
| Molecular Medicine | 1/165 | Q1 | T1 | D1 |
SJR año:
2019
Factor de Impacto:
9,340
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Cell Biology | 11/313 | Q1 | T1 | D1 |
| Genetics | 4/372 | Q1 | T1 | D1 |
| Molecular Medicine | 2/185 | Q1 | T1 | D1 |
| Agencia | Código de Proyecto |
|---|---|
| Cancer Research UK | - |
| ConSEPOC-Comunidad de Madrid | S2010/BMD-2542 |
| European Union | ERC-2014-CoG-64765; FP7-PEOPLE-2011-RG-294096 |
| Fondo Europeo de Desarrollo Regional (FEDER, "Una manera de hacer Europa\'\') | SAF2016-79490-R |
| Fundacio Marato TV3 | 122/C/2015 |
| Howard Hughes Medical Institute | - |
| Instituto de Salud Carlos III | AC16/00091; AC17/00067 |
| Instituto de Salud Carlos III (ISCIII) | - |
| LaCaixa Foundation | - |
| Marie Curie Career Integration | H2020-MSCA-IF-2015-70841 |
| MEIC | SAF-2011-30308 |
| Ministerio de Ciencia, Innovacion y Universidades (MCIU) | - |
| MRC | - |
| National Health Service Blood and Transplant (United Kingdom) | - |
| Pro CNIC Foundation | - |
| Progeria Research Foundation | 2014-52 |
| R.O.C. Government Scholarship to Study Abroad (GSSA) | - |
| Ramon Areces Foundation | - |
| Ramon y Cajal Program Grant | RYC-2009-04703 |
| Red TerCel (ISCIII-Spanish Cell Therapy Network) | - |
| Severo Ochoa Center of Excellence | SEV-2015-0505 |
| Spanish Ministerio de Economia, Industria y Competitividad (MEIC) | - |
| University of Cambridge | - |
| Wellcome Trust | - |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Ho, Ya Hsuan | University of Cambridge; NHS Blood and Transplant (United Kingdom) |
| 2 | Toro, Raquel del | Centro Nacional de Investigaciones Cardiovasculares Carlos III; CIBER de Enfermedades Cardiovasculares (CIBERCV) (Spain) |
| 3 | Rivera-Torres, José | Centro Nacional de Investigaciones Cardiovasculares Carlos III; CIBER de Enfermedades Cardiovasculares (CIBERCV) (Spain) |
| 4 | Rak, Justyna | University of Cambridge; NHS Blood and Transplant (United Kingdom) |
| 5 | Korn, Claudia | University of Cambridge; NHS Blood and Transplant (United Kingdom) |
| 6 | García-García, Andrés | University of Cambridge; Centro Nacional de Investigaciones Cardiovasculares Carlos III; NHS Blood and Transplant (United Kingdom) |
| 7 | Macías, David | University of Cambridge (United Kingdom) |
| 8 | González-Gómez, Cristina | Centro Nacional de Investigaciones Cardiovasculares Carlos III; CIBER de Enfermedades Cardiovasculares (CIBERCV) (Spain) |
| 9 | del Monte, Alberto | Centro Nacional de Investigaciones Cardiovasculares Carlos III; CIBER de Enfermedades Cardiovasculares (CIBERCV) (Spain) |
| 10 | Wittner, Monika | Universite Paris-Saclay (France) |
| 11 | Waller, Amie K. | University of Cambridge; NHS Blood and Transplant (United Kingdom) |
| 12 | Foster, Holly R. | University of Cambridge; NHS Blood and Transplant (United Kingdom) |
| 13 | López-Otín, Carlos | Instituto Universitario de Oncologia del Principado de Asturias; CIBERONC (Spain) |
| 14 | Johnson, Randall S. | University of Cambridge (United Kingdom) |
| 15 | Nerlov, Claus | MRC Weatherall Institute of Molecular Medicine (United Kingdom) |
| 16 | Ghevaert, Cedric | University of Cambridge; NHS Blood and Transplant (United Kingdom) |
| 17 | Vainchenker, William | Universite Paris-Saclay (France) |
| 18 | Louache, Fawzia | Universite Paris-Saclay (France) |
| 19 | Andrés, Vicente | Centro Nacional de Investigaciones Cardiovasculares Carlos III; CIBER de Enfermedades Cardiovasculares (CIBERCV) (Spain) |
| 20 | University of Cambridge; Centro Nacional de Investigaciones Cardiovasculares Carlos III; NHS Blood and Transplant (United Kingdom) |
